NEW YORK (dpa-AFX Broker) - The analyst firm Jefferies has raised the target price for Sartorius from 313 to 359 euros, but left the rating at "Hold". The higher price target reflects the recent capital measures of Sartorius and Sartorius Stedim Biotech, analyst James Vane-Tempest wrote in a study published on Tuesday. Lower debt will benefit earnings per share. The price target of laboratory equipment supplier Sartorius also benefits from a lower weighted average cost of capital./bek/tav

Publication of the original study: 11.03.2024 / 13:44 / ET

First dissemination of the original study: 11.03.2024 / 20:00 / ET

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------